Anyone out there know anything about how its working or happen to participate in "An Extended- Phase 2 Multi-Center, Open-Label Study to Evaluate the Tolerability of GT0918 in Subjects With Metastatic Castrate Resistant Prostate Caner (mCRPC)"
The Proxiludamide (GT0918) Trials are scattered around USA and from What I've been able to glean is that its suppose to be about 5 X's stronger that Xtandi or Zytiga with the two Arms of the trial involve finding the best effective tolerated dosage of either one time pill of 400 mg daily or 500 mg daily. Mega Thanks...Tgrec